ENTO · Categories · Form 4
ENTO - SEC Form 4 insider transactions
Entero Therapeutics Inc. (ENTO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for ENTO
- Chief Financial Officer Romano Sarah sold $465 worth of shares (727 units at $0.64), decreasing direct ownership by 4% to 17,287 units (SEC Form 4)4 - Entero Therapeutics, Inc. (0001604191) (Issuer)
- Chief Financial Officer Romano Sarah sold $212 worth of shares (476 units at $0.45), decreasing direct ownership by 3% to 18,014 units (SEC Form 4)4 - Entero Therapeutics, Inc. (0001604191) (Issuer)
- Chief Financial Officer Romano Sarah sold $664 worth of shares (621 units at $1.07), decreasing direct ownership by 3% to 18,490 units (SEC Form 4)4 - Entero Therapeutics, Inc. (0001604191) (Issuer)
- Chairman and CEO Sapirstein James sold $1,379 worth of shares (1,289 units at $1.07), decreasing direct ownership by 3% to 35,816 units (SEC Form 4)4 - Entero Therapeutics, Inc. (0001604191) (Issuer)
- Director Khosla Chaitan Phd was granted 24,889 shares (SEC Form 4)4 - Entero Therapeutics, Inc. (0001604191) (Issuer)